Kintara TherapeuticsKTRA 
$0.18-8.38%24h
-8.38%24h
Global rank
Market cap$283.50K
Change 7d-
YTD Performance7.36%
SP500 benchmarkUnderperform
P/E-0.02
P/S0
Revenue$0
Earnings-$14.65M
Dividend yield-
Main Sector
Healthcare
Category
EPS for Kintara Therapeutics (KTRA)
Kintara Therapeutics has an EPS of $-9.27. In 2022, the company made an earnings per share (EPS) of $-25.8. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for KTRA
-
Value:-
EPS history for Kintara Therapeutics from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$9.27 | -64.07% |
| 2022 | -$25.80 | -67.75% |
| 2021 | -$80.00 | 83.91% |
| 2020 | -$43.50 | - |
View the highest EPS stocks
